The Brigatinib Tablet market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Brigatinib Tablet size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Brigatinib Tablet market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Brigatinib Tablet market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
30mg
50mg
180mg
Market segment by Application can be divided into
Hospital
Pharmacy
The key market players for global Brigatinib Tablet market are listed below:
ARIAD Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Brigatinib Tablet product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Brigatinib Tablet, with price, sales, revenue and global market share of Brigatinib Tablet in 2018 and 2019.
Chapter 3, the Brigatinib Tablet competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Brigatinib Tablet breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Brigatinib Tablet market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Brigatinib Tablet sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Brigatinib Tablet Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Brigatinib Tablet Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 30mg
1.2.3 50mg
1.2.4 180mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Brigatinib Tablet Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Brigatinib Tablet Market Size & Forecast
1.4.1 Global Brigatinib Tablet Sales in Value (2016-2026))
1.4.2 Global Brigatinib Tablet Sales in Volume (2016-2026)
1.4.3 Global Brigatinib Tablet Price by Type (2016-2026) & (USD/MT)
1.5 Global Brigatinib Tablet Production Capacity Analysis
1.5.1 Global Brigatinib Tablet Total Production Capacity (2016-2026)
1.5.2 Global Brigatinib Tablet Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Brigatinib Tablet Market Drivers
1.6.2 Brigatinib Tablet Market Restraints
1.6.3 Brigatinib Tablet Trends Analysis
2 Manufacturers Profiles
2.1 ARIAD Pharmaceuticals
2.1.1 ARIAD Pharmaceuticals Details
2.1.2 ARIAD Pharmaceuticals Major Business
2.1.3 ARIAD Pharmaceuticals Brigatinib Tablet Product and Services
2.1.4 ARIAD Pharmaceuticals Brigatinib Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Brigatinib Tablet Sales by Manufacturer
3.1 Global Brigatinib Tablet Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Brigatinib Tablet Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Brigatinib Tablet
3.4 Market Concentration Rate
3.4.1 Top 3 Brigatinib Tablet Manufacturer Market Share
3.4.2 Top 6 Brigatinib Tablet Manufacturer Market Share
3.5 Global Brigatinib Tablet Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Brigatinib Tablet Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Brigatinib Tablet Market Size by Region
4.1.1 Global Brigatinib Tablet Sales in Volume by Region (2016-2026)
4.1.2 Global Brigatinib Tablet Revenue by Region (2016-2026)
4.2 North America Brigatinib Tablet Revenue (2016-2026)
4.3 Europe Brigatinib Tablet Revenue (2016-2026)
4.4 Asia-Pacific Brigatinib Tablet Revenue (2016-2026)
4.5 South America Brigatinib Tablet Revenue (2016-2026)
4.6 Middle East and Africa Brigatinib Tablet Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Brigatinib Tablet Sales in Volume by Type (2016-2026)
5.2 Global Brigatinib Tablet Revenue by Type (2016-2026)
5.3 Global Brigatinib Tablet Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Brigatinib Tablet Sales in Volume by Application (2016-2026)
6.2 Global Brigatinib Tablet Revenue by Application (2016-2026)
6.3 Global Brigatinib Tablet Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Brigatinib Tablet Sales by Type (2016-2026)
7.2 North America Brigatinib Tablet Sales by Application (2016-2026)
7.3 North America Brigatinib Tablet Market Size by Country
7.3.1 North America Brigatinib Tablet Sales in Volume by Country (2016-2026)
7.3.2 North America Brigatinib Tablet Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Brigatinib Tablet Sales by Type (2016-2026)
8.2 Europe Brigatinib Tablet Sales by Application (2016-2026)
8.3 Europe Brigatinib Tablet Market Size by Country
8.3.1 Europe Brigatinib Tablet Sales in Volume by Country (2016-2026)
8.3.2 Europe Brigatinib Tablet Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Brigatinib Tablet Sales by Type (2016-2026)
9.2 Asia-Pacific Brigatinib Tablet Sales by Application (2016-2026)
9.3 Asia-Pacific Brigatinib Tablet Market Size by Region
9.3.1 Asia-Pacific Brigatinib Tablet Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Brigatinib Tablet Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Brigatinib Tablet Sales by Type (2016-2026)
10.2 South America Brigatinib Tablet Sales by Application (2016-2026)
10.3 South America Brigatinib Tablet Market Size by Country
10.3.1 South America Brigatinib Tablet Sales in Volume by Country (2016-2026)
10.3.2 South America Brigatinib Tablet Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Brigatinib Tablet Sales by Type (2016-2026)
11.2 Middle East & Africa Brigatinib Tablet Sales by Application (2016-2026)
11.3 Middle East & Africa Brigatinib Tablet Market Size by Country
11.3.1 Middle East & Africa Brigatinib Tablet Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Brigatinib Tablet Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Brigatinib Tablet Typical Distributors
12.3 Brigatinib Tablet Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Brigatinib Tablet Revenue by Type, (USD Million), 2021-2026
Table 2. Global Brigatinib Tablet Revenue by Application, (USD Million), 2021-2026
Table 3. ARIAD Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. ARIAD Pharmaceuticals Major Business
Table 5. ARIAD Pharmaceuticals Brigatinib Tablet Product and Services
Table 6. ARIAD Pharmaceuticals Brigatinib Tablet Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Brigatinib Tablet Sales by Manufacturer (2019-2021e) & (K MT)
Table 8. Global Brigatinib Tablet Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Brigatinib Tablet, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Brigatinib Tablet Production Capacity by Company, (K MT): 2020 VS 2021
Table 11. Head Office and Brigatinib Tablet Production Site of Key Manufacturer
Table 12. Brigatinib Tablet New Entrant and Capacity Expansion Plans
Table 13. Brigatinib Tablet Mergers & Acquisitions in the Past Five Years
Table 14. Global Brigatinib Tablet Sales by Region (2016-2021e) & (K MT)
Table 15. Global Brigatinib Tablet Sales by Region (2021-2026) & (K MT)
Table 16. Global Brigatinib Tablet Revenue by Region (2016-2021e) & (USD Million)
Table 17. Global Brigatinib Tablet Revenue by Region (2021-2026) & (USD Million)
Table 18. Global Brigatinib Tablet Sales by Type (2016-2021e) & (K MT)
Table 19. Global Brigatinib Tablet Sales by Type (2021-2026) & (K MT)
Table 20. Global Brigatinib Tablet Revenue by Type (2016-2021e) & (USD Million)
Table 21. Global Brigatinib Tablet Revenue by Type (2021-2026) & (USD Million)
Table 22. Global Brigatinib Tablet Price by Type (2016-2021e) & (USD/MT)
Table 23. Global Brigatinib Tablet Price by Type (2021-2026) & (USD/MT)
Table 24. Global Brigatinib Tablet Sales by Application (2016-2021e) & (K MT)
Table 25. Global Brigatinib Tablet Sales by Application (2021-2026) & (K MT)
Table 26. Global Brigatinib Tablet Revenue by Application (2016-2021e) & (USD Million)
Table 27. Global Brigatinib Tablet Revenue by Application (2021-2026) & (USD Million)
Table 28. Global Brigatinib Tablet Price by Application (2016-2021e) & (USD/MT)
Table 29. Global Brigatinib Tablet Price by Application (2021-2026) & (USD/MT)
Table 30. North America Brigatinib Tablet Sales by Country (2016-2021e) & (K MT)
Table 31. North America Brigatinib Tablet Sales by Country (2021-2026) & (K MT)
Table 32. North America Brigatinib Tablet Revenue by Country (2016-2021e) & (USD Million)
Table 33. North America Brigatinib Tablet Revenue by Country (2021-2026) & (USD Million)
Table 34. North America Brigatinib Tablet Sales by Type (2016-2021e) & (K MT)
Table 35. North America Brigatinib Tablet Sales by Type (2021-2026) & (K MT)
Table 36. North America Brigatinib Tablet Sales by Application (2016-2021e) & (K MT)
Table 37. North America Brigatinib Tablet Sales by Application (2021-2026) & (K MT)
Table 38. Europe Brigatinib Tablet Sales by Country (2016-2021e) & (K MT)
Table 39. Europe Brigatinib Tablet Sales by Country (2021-2026) & (K MT)
Table 40. Europe Brigatinib Tablet Revenue by Country (2016-2021e) & (USD Million)
Table 41. Europe Brigatinib Tablet Revenue by Country (2021-2026) & (USD Million)
Table 42. Europe Brigatinib Tablet Sales by Type (2016-2021e) & (K MT)
Table 43. Europe Brigatinib Tablet Sales by Type (2021-2026) & (K MT)
Table 44. Europe Brigatinib Tablet Sales by Application (2016-2021e) & (K MT)
Table 45. Europe Brigatinib Tablet Sales by Application (2021-2026) & (K MT)
Table 46. Asia-Pacific Brigatinib Tablet Sales by Region (2016-2021e) & (K MT)
Table 47. Asia-Pacific Brigatinib Tablet Sales by Region (2021-2026) & (K MT)
Table 48. Asia-Pacific Brigatinib Tablet Revenue by Region (2016-2021e) & (USD Million)
Table 49. Asia-Pacific Brigatinib Tablet Revenue by Region (2021-2026) & (USD Million)
Table 50. Asia-Pacific Brigatinib Tablet Sales by Type (2016-2021e) & (K MT)
Table 51. Asia-Pacific Brigatinib Tablet Sales by Type (2021-2026) & (K MT)
Table 52. Asia-Pacific Brigatinib Tablet Sales by Application (2016-2021e) & (K MT)
Table 53. Asia-Pacific Brigatinib Tablet Sales by Application (2021-2026) & (K MT)
Table 54. South America Brigatinib Tablet Sales by Country (2016-2021e) & (K MT)
Table 55. South America Brigatinib Tablet Sales by Country (2021-2026) & (K MT)
Table 56. South America Brigatinib Tablet Revenue by Country (2016-2021e) & (USD Million)
Table 57. South America Brigatinib Tablet Revenue by Country (2021-2026) & (USD Million)
Table 58. South America Brigatinib Tablet Sales by Type (2016-2021e) & (K MT)
Table 59. South America Brigatinib Tablet Sales by Type (2021-2026) & (K MT)
Table 60. South America Brigatinib Tablet Sales by Application (2016-2021e) & (K MT)
Table 61. South America Brigatinib Tablet Sales by Application (2021-2026) & (K MT)
Table 62. Middle East & Africa Brigatinib Tablet Sales by Country (2016-2021e) & (K MT)
Table 63. Middle East & Africa Brigatinib Tablet Sales by Country (2021-2026) & (K MT)
Table 64. Middle East & Africa Brigatinib Tablet Revenue by Country (2016-2021e) & (USD Million)
Table 65. Middle East & Africa Brigatinib Tablet Revenue by Country (2021-2026) & (USD Million)
Table 66. Middle East & Africa Brigatinib Tablet Sales by Type (2016-2021e) & (K MT)
Table 67. Middle East & Africa Brigatinib Tablet Sales by Type (2021-2026) & (K MT)
Table 68. Middle East & Africa Brigatinib Tablet Sales by Application (2016-2021e) & (K MT)
Table 69. Middle East & Africa Brigatinib Tablet Sales by Application (2021-2026) & (K MT)
Table 70. Direct Channel Pros & Cons
Table 71. Indirect Channel Pros & Cons
Table 72. Brigatinib Tablet Typical Distributors
Table 73. Brigatinib Tablet Typical Customers
List of Figures
Figure 1. Brigatinib Tablet Picture
Figure 2. Global Brigatinib Tablet Sales Market Share by Type in 2020
Figure 3. 30mg
Figure 4. 50mg
Figure 5. 180mg
Figure 6. Global Brigatinib Tablet Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Pharmacy
Figure 9. Global Brigatinib Tablet Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 10. Global Brigatinib Tablet Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Brigatinib Tablet Sales (2016-2026) & (K MT)
Figure 12. Global Brigatinib Tablet Price by Type (2016-2026) & (USD/MT)
Figure 13. Global Brigatinib Tablet Production Capacity (2016-2026) & (K MT)
Figure 14. Global Brigatinib Tablet Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Brigatinib Tablet Market Drivers
Figure 16. Brigatinib Tablet Market Restraints
Figure 17. Brigatinib Tablet Market Trends
Figure 18. Global Brigatinib Tablet Sales Market Share by Manufacturer in 2020
Figure 19. Global Brigatinib Tablet Revenue Market Share by Manufacturer in 2020
Figure 20. Brigatinib Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Brigatinib Tablet Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Brigatinib Tablet Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Brigatinib Tablet Sales Market Share by Region (2016-2026)
Figure 24. Global Brigatinib Tablet Revenue Market Share by Region (2016-2026)
Figure 25. North America Brigatinib Tablet Revenue (2016-2026) & (USD Million)
Figure 26. Europe Brigatinib Tablet Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Brigatinib Tablet Revenue (2016-2026) & (USD Million)
Figure 28. South America Brigatinib Tablet Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Brigatinib Tablet Revenue (2016-2026) & (USD Million)
Figure 30. Global Brigatinib Tablet Sales Market Share by Type (2016-2026)
Figure 31. Global Brigatinib Tablet Revenue Market Share by Type (2016-2026)
Figure 32. Global Brigatinib Tablet Price by Type (2016-2026) & (USD/MT)
Figure 33. Global Brigatinib Tablet Sales Market Share by Application (2016-2026)
Figure 34. Global Brigatinib Tablet Revenue Market Share by Application (2016-2026)
Figure 35. Global Brigatinib Tablet Price by Application (2016-2026) & (USD/MT)
Figure 36. North America Brigatinib Tablet Sales Market Share by Type (2016-2026)
Figure 37. North America Brigatinib Tablet Sales Market Share by Application (2016-2026)
Figure 38. North America Brigatinib Tablet Sales Market Share by Country (2016-2026)
Figure 39. North America Brigatinib Tablet Revenue Market Share by Country (2016-2026)
Figure 40. United States Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Brigatinib Tablet Sales Market Share by Type (2016-2026)
Figure 44. Europe Brigatinib Tablet Sales Market Share by Application (2016-2026)
Figure 45. Europe Brigatinib Tablet Sales Market Share by Country (2016-2026)
Figure 46. Europe Brigatinib Tablet Revenue Market Share by Country (2016-2026)
Figure 47. Germany Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Brigatinib Tablet Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Brigatinib Tablet Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Brigatinib Tablet Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Brigatinib Tablet Revenue Market Share by Region (2016-2026)
Figure 56. China Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Brigatinib Tablet Sales Market Share by Type (2016-2026)
Figure 63. South America Brigatinib Tablet Sales Market Share by Application (2016-2026)
Figure 64. South America Brigatinib Tablet Sales Market Share by Country (2016-2026)
Figure 65. South America Brigatinib Tablet Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Brigatinib Tablet Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Brigatinib Tablet Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Brigatinib Tablet Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Brigatinib Tablet Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Brigatinib Tablet Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source